IDEXX Laboratories, Inc.
IDXX
$430.12
$1.090.25%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 887.87M | 866.24M | 845.63M | 866.57M | 845.04M |
Total Depreciation and Amortization | 129.94M | 125.97M | 120.82M | 116.48M | 114.91M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 44.44M | 7.30M | 11.99M | 21.37M | 18.99M |
Change in Net Operating Assets | -133.24M | -82.68M | -9.25M | -83.24M | -72.43M |
Cash from Operations | 929.00M | 916.83M | 969.18M | 921.18M | 906.51M |
Capital Expenditure | -120.92M | -124.22M | -130.23M | -124.39M | -133.63M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -76.69M | -76.69M | -77.00M | -77.00M | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -9.45M | 3.26M | 9.10M | 8.71M | 8.38M |
Cash from Investing | -207.06M | -197.65M | -198.12M | -192.69M | -125.25M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -75.00M | -150.00M | -87.22M | -254.72M | -404.00M |
Issuance of Common Stock | 44.49M | 42.57M | 50.19M | 55.12M | 47.03M |
Repurchase of Common Stock | -847.57M | -638.45M | -452.77M | -237.25M | -81.90M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -1.26M | -9.39M | -3.14M | -3.14M |
Cash from Financing | -878.07M | -747.14M | -499.19M | -439.99M | -442.00M |
Foreign Exchange rate Adjustments | -9.53M | 4.90M | -3.11M | -2.44M | 2.13M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -165.67M | -23.06M | 268.75M | 286.07M | 341.39M |